BRATTON DOUGLAS K

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$14.85M
Insider Sells Quantity
12
Insider Sells Sum
$335.63M

Insider Activity of BRATTON DOUGLAS K

The largest purchase of all time was on 2017-12-12 and amounted to 550000 shares of Denali Therapeutics Inc. for $9.9M.

The largest sale of all time was on 2021-02-12 and amounted to 2216798 shares of Denali Therapeutics Inc. for $144.09M.

Biography of BRATTON DOUGLAS K

No biography is available at this moment.

2021-02-12SaleDenali Therapeutics Inc.
DNLI
10 percent owner
2.22M
1.7656%
$65.00$144.09M-21.69%
2020-12-14SaleDenali Therapeutics Inc.
DNLI
10 percent owner
17,825
0.0145%
$80.38$1.43M-32.55%
2020-12-11SaleDenali Therapeutics Inc.
DNLI
10 percent owner
46,799
0.039%
$80.05$3.75M-30.52%
2020-08-12SaleDenali Therapeutics Inc.
DNLI
10 percent owner
1.44M
1.4189%
$31.65$45.68M+104.19%
2020-06-30SaleDenali Therapeutics Inc.
DNLI
10 percent owner
45,345
0.0419%
$24.01$1.09M+135.5%
2020-06-29SaleDenali Therapeutics Inc.
DNLI
10 percent owner
82,578
0.0791%
$24.01$1.98M+139.28%
2020-06-26SaleDenali Therapeutics Inc.
DNLI
10 percent owner
122,077
0.1161%
$23.94$2.92M+135.46%
2020-06-23SaleDenali Therapeutics Inc.
DNLI
10 percent owner
20,024
0.0186%
$25.77$515,969+112.57%
2020-06-22SaleDenali Therapeutics Inc.
DNLI
10 percent owner
90,056
0.0848%
$24.78$2.23M+123.33%
2020-06-19SaleDenali Therapeutics Inc.
DNLI
10 percent owner
144,920
0.1425%
$24.54$3.56M+135.11%
2020-06-05SaleDenali Therapeutics Inc.
DNLI
10 percent owner
1.92M
1.8062%
$25.75$49.51M+109.41%
2020-02-26SaleDenali Therapeutics Inc.
DNLI
10 percent owner
3.89M
3.5601%
$20.25$78.87M+47.9%
2018-07-24PurchaseAquestive Therapeutics, Inc.
AQST
330,000
1.3043%
$15.00$4.95M
2017-12-12PurchaseDenali Therapeutics Inc.
DNLI
10 percent owner
550,000
1.5973%
$18.00$9.9M-7.19%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.